Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus

QR Code

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus

Daniel Lorber Division of Endocrinology, New York Hospital Queens, Department of Medicine, Weill Medical College of Cornell University, New York, NY, USA Abstract: Type 2 diabetes mellitus (T2DM) is commonly accompanied by other cardiovascular disease (CVD) risk factors, such as hypertension, obes...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Lorber D
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2014
Sujets:	Specialties of internal medicine RC581-951
Accès en ligne:	https://doaj.org/article/2d1687548a0c40f4aedef0f84be0c23d
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
par: Pamela Kushner
Publié: (2010)

Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
par: Ogedengbe OS, et autres
Publié: (2015)

Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
par: Peter J Donovan, et autres
Publié: (2010)

Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
par: Anderson M, et autres
Publié: (2014)

Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management
par: Nitzan O, et autres
Publié: (2015)

Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
par: Yang F, et autres
Publié: (2015)

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
par: Alaa Badawi, et autres
Publié: (2010)

Risk management in the treatment of type 2 diabetes with pioglitazone
par: Giuseppe Derosa, et autres
Publié: (2009)

Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus
par: Feher M, et autres
Publié: (2013)

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
par: Omoto S, et autres
Publié: (2015)

Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting
par: Ofori SN, et autres
Publié: (2014)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated
par: Irons BK, et autres
Publié: (2014)

Magnitude of, and Factors Associated with Cardiovascular Disease Among Type Two Diabetes Mellitus Patients
par: Tesfaye A, et autres
Publié: (2020)

Management of gestational diabetes mellitus
par: Annunziata Lapolla, et autres
Publié: (2009)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
par: Irons BK, et autres
Publié: (2017)

Effects of a moderate low-carbohydrate diet on preferential abdominal fat loss and cardiovascular risk factors in patients with type 2 diabetes
par: Sasakabe T, et autres
Publié: (2011)

Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus
par: Mazzilli R, et autres
Publié: (2015)

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
par: Shannon A Miller, et autres
Publié: (2009)

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
par: Jean-Pierre Le Floch
Publié: (2010)

Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study
par: Penfornis A, et autres
Publié: (2015)

Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin
par: Ohira M, et autres
Publié: (2014)

Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus
par: Konya H, et autres
Publié: (2013)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
par: Holl, et autres
Publié: (2014)

Type 2 diabetes in Brazil: epidemiology and management
par: Almeida-Pititto B, et autres
Publié: (2015)

Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review
par: Colosia AD, et autres
Publié: (2013)

Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
par: Petersen AB, et autres
Publié: (2013)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
par: Stanley Schwartz, et autres
Publié: (2010)

Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions
par: Angel Rodr&iacute;guez, et autres
Publié: (2010)

TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
par: Shitalkumar P Zambad, et autres
Publié: (2011)

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]
par: Wilke T, et autres
Publié: (2019)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
par: Jason Seewoodhary, et autres
Publié: (2010)

Fixed combination of repaglinide and metformin in the management of type 2 diabetes
par: Robert Moses
Publié: (2009)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
par: Joshua J Neumiller, et autres
Publié: (2010)

Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase&ndash;lowering effects of garlic in patients with type 2 diabetes mellitus with obesity
par: Kumar R, et autres
Publié: (2013)

Glucose estimation in the salivary secretion of diabetes mellitus patients
par: Abikshyeet P, et autres
Publié: (2012)

Long-term (52&ndash;78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients
par: Bays HE
Publié: (2012)

Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes
par: Cyrus&nbsp;V Desouza, et autres
Publié: (2009)

Clinical potential of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes
par: Kim Y, et autres
Publié: (2012)

Using the health action process approach to predict and improve health outcomes in individuals with type 2 diabetes mellitus
par: MacPhail M, et autres
Publié: (2014)

New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin
par: Baptist Gallwitz
Publié: (2010)